Beck Mack & Oliver’s Exelixis EXEL Stock Holding History

Beck Mack & Oliver’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,000	Closed	-$67K	–	302
2015 Q3	$67K	Hold	12,000	–	–	﹤0.01%	310
2015 Q2	$45K	Hold	12,000	–	–	﹤0.01%	340
2015 Q1	$31K	Hold	12,000	–	–	﹤0.01%	357
2014 Q4	$17K	Hold	12,000	–	–	﹤0.01%	359
2014 Q3	$18K	Hold	12,000	–	–	﹤0.01%	362
2014 Q2	$41K	Buy	+12,000	New	+$41.4K	﹤0.01%	365

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Beck Mack & Oliver's EXEL Position: Q4 2015 in Review

Beck Mack & Oliver sold out of Exelixis (EXEL) in Q4 2015, closing a stake of 12,000 shares — an estimated $67K sold.

Beck Mack & Oliver first reported a position in EXEL in Q2 2014 and held it in 6 quarters. The position peaked at $67K in Q3 2015. 146 funds tracked by Wall St. Rank hold EXEL as of Q4 2015.

Beck Mack & Oliver reported no remaining Exelixis position as of Q4 2015 after selling out during the quarter.
Beck Mack & Oliver sold 12,000 Exelixis shares in Q4 2015, an estimated $67K.
Beck Mack & Oliver first reported a position in Exelixis in Q2 2014 and held it in 6 quarters.
Beck Mack & Oliver's Exelixis position peaked at $67K in Q3 2015.
146 funds tracked by Wall St. Rank held Exelixis as of Q4 2015.

Based on Beck Mack & Oliver's 13F filing for Q4 2015, filed 1 Feb 2016.